NCT02092818View on ClinicalTrials.gov

EXPERT, EXPosurE Registry RiociguaT in Patients With Pulmonary Hypertension

CompletedOBSERVATIONAL
Enrollment

1,316

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

March 31, 2018

Study Completion Date

June 29, 2018

Conditions
Hypertension, Pulmonary
Interventions
DRUG

Riociguat (Adempas, BAY63-2521)

The decision on clinical management of the patient including the actual treatment duration will be determined solely by the physician not by the clinical study protocol (CSP)

Trial Locations (28)

Unknown

Multiple Locations

Multiple Locations

Multiple Locations

Multiple Locations

Multiple Locations

Multiple Locations

Multiple Locations

Multiple Locations

Multiple Locations

Multiple Locations

Multiple Locations

Multiple Locations

Multiple Locations

Multiple Locations

Multiple Locations

Multiple Locations

Multiple Locations

Multiple Locations

Multiple Locations

Multiple Locations

Multiple Locations

Multiple Locations

Multiple Locations

Multiple Locations

Multiple Locations

Multiple Locations

Multiple Locations

Multiple Locations

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
lead

Bayer

INDUSTRY

NCT02092818 - EXPERT, EXPosurE Registry RiociguaT in Patients With Pulmonary Hypertension | Biotech Hunter | Biotech Hunter